Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2015-04-24 | fluciclovine (18F) | Blue Earth Diagnostics (UK) | glioma |
Granting of the orphan status in the EU |
2015-04-24 | pelareorep (human reovirus type 3 Dearing strain) | Oncolytics Biotech (Canada) | pancreatic cancer |
Granting of the orphan status in the EU |
2015-04-15 | pelareorep (human reovirus type 3 Dearing strain) | Oncolytics Biotech (Canada) | malignant glioma |
Granting of the orphan status in the US |
2015-04-24 | ecothiophate iodide | JJGConsultancy (UK) | Stargardt’s disease |
Granting of the orphan status in the EU |
2015-04-29 | lenalidomide | Celgene (USA - NJ) | marginal zone lymphoma extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue |
Granting of the orphan status in the US |
2015-04-24 | rimeporide | EUDRAC (UK) | Duchenne muscular dystrophy |
Granting of the orphan status in the EU |
2015-04-24 | rintatolimod | Hemispherx BioPharma (USA - PA) | Ebola fever |
Granting of the orphan status in the EU |
2015-04-24 | recombinant monoclonal IgG1 antibody against T-cell immune response cDNA 7 | Nekonal (Luxemburg) | graft rejection following solid organ transplantation |
Granting of the orphan status in the EU |
2015-04-24 | adeno-associated viral vector serotype 5 containing the human CHM gene | Horama (France) | choroideremia |
Granting of the orphan status in the EU |
2015-04-24 | nitric oxide | Biological Consulting Europe (UK) | cystic fibrosis |
Granting of the orphan status in the EU |
2015-04-24 | phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis(1,1-dimethylethyl) monohydrochloride | Ipsen (France) | Huntington’s disease |
Granting of the orphan status in the EU |
2015-04-24 | recombinant human mesencephalic astrocyte-derived neurotrophic factor | Clinipace (Germany) | retinitis pigmentosa |
Granting of the orphan status in the EU |
2015-08-25 | sodium 2-hydroxylinoleate | Ability Pharmaceuticals (Spain) | neuroblastoma |
Granting of the orphan status in the US |
2015-04-24 | xenon | Neuroprotexeon (UK) | perinatal asphyxia |
Granting of the orphan status in the EU |
2015-04-15 | tremelimumab | AstraZeneca (UK) | mesothelioma |
Granting of the orphan status in the US |
2015-04-17 | selumetinib | AstraZeneca (UK) | uveal melanoma |
Granting of the orphan status in the US |
2017-05-11 | autologous stem cells | Celyad, previously known as Cardio3 BioSciences (Belgium) | ischemic heart failure | Granting of a Fast Track status |
2015-04-07 | TCR-deficient T-Cells engineered to express a chimeric antigen receptor | Cardio3 BioSciences (Belgium) | Granting of a patent | |
2015-04-20 | minocycline | The Medicines Company (USA - NJ) | infections due to susceptible strains of important designated gram-positive and gram-negative pathogens, including infections due to Acinetobacter species | Granting of a Market Authorisation in the US |
2015-04-21 | L-asparaginase encapsulated in erythrocytes | Erytech Pharma (France) | pancreatic cancer | Granting of a patent |
© 2024 Biopharmanalyses - Powered by Samacom+